
|Videos|April 29, 2022
Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline
Author(s)Kassi Filkins
Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
2
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
3
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5


























